483 Antares Pharma May 2022

483 Antares Pharma May 2022

Brian Nicholson FDA$119.00 - Available Now

FDA investigators audited the Antares Pharma - Minnetonka, MN, United States facility and issued inspectional observations (via FDA 483) on 13 May 2022.

Product details

  • Category: Human Drugs
  • Inspection end: 13 May 2022
  • Location: Minnetonka, United States
  • FEI: 2182861
Add To Cart